Ranked #10 of 497 · scores higher than 98% of peers · safety percentile 98
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)
55 peers with a safety percentile of 90–100, including JBIO · Click a bar to see the companies
Why “Lower relative risk”?
The measures below combine into a safety percentile of 98 among Healthcare companies. It is relative: 67 or more is lower relative risk, 33–66 moderate, below 33 higher.
Mainly thanks to its debt / equity and current ratio, which are stronger than most Healthcare peers.
●Beta is not reported, so it is left out of the score.
▲more short-term assets to cover bills due within a year: stronger than 93% of peers. Current ratio: 14.93× vs peer median 2.59×
▲less borrowing relative to shareholders' equity: stronger than 96% of peers. Debt / equity: <0.01× vs peer median 0.22×
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
Metric by metric
Position: dot = JBIO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.
Metric
JBIO
Peer median
Better than
Position among peers
Weight
Debt / equityLower is better · 465 reported
0.00×
0.18×
95%
33%
BetaLower is better · 469 reported
Not reported
0.45
—
—
33%
Current ratioHigher is better · 486 reported
14.93×
2.87×
93%
33%
A metric that is not reported is left out of the score; the other weights are rescaled.
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
